Prostamax 20 mg

Prostamax is a synthetic bioactive tetrapeptide belonging to the peptide bioregulator family. It is studied for its regulatory effects on prostate cellular function, tissue maintenance, and inflammatory balance. Research interest centers on its role in supporting prostate tissue integrity, modulating immune responses, and influencing age-related cellular processes.

(Khavinson et al., 2009 — Advances in Gerontology).

Prostamax has been investigated in experimental models related to prostate health, including cellular metabolism regulation, tissue regeneration pathways, chromatin structure modulation, and immune-mediated inflammatory control.

The peptide is supplied as a lyophilized powder to ensure optimal stability during storage and handling.

Prostamax Overview

Prostamax is a low–molecular weight regulatory peptide designed to interact with intracellular signaling pathways relevant to prostate cell metabolism, proliferation, and differentiation. Due to its compact structure, it is studied for its ability to influence cellular homeostasis without inducing irreversible cellular inhibition.

Unlike conventional prostate-targeted agents, Prostamax functions as a signaling regulator, making it a valuable research compound for studying controlled tissue regeneration, inflammation balance, and cellular aging processes within prostate-associated research models.